NICE Powers Acceleration of COVID-19 Vaccine Global Distribution Effort
January 05 2021 - 10:14AM
Business Wire
NICE inContact CXone streamlines vaccine
distribution supply chain from vaccine producers to healthcare
providers, allowing a faster and efficient process
NICE (Nasdaq: NICE) today announced that it is ramping up
support for service and information centers across the entire
COVID-19 vaccine supply chain with its CXone cloud platform. The
vaccine supply chain is comprised of three main critical
stakeholders: vaccine manufacturers, federal and state agencies
responsible for distribution and healthcare providers that are
administering the vaccine. As governments around the globe are
working diligently to build and scale this supply chain, NICE CXone
plays a critical role in eliminating bottlenecks, ensuring a smooth
process and guaranteeing flawless and clear communication
throughout.
Organizations are now working to quickly supply and administer
tens of millions of doses worldwide to help end the devastating
pandemic. They are moving quicker than ever before to produce,
distribute and communicate about the vaccine and need a reliable
platform to allow them to be successful. For example, two of the
leading approved vaccine manufacturers are now using CXone, dozens
of state and government agencies are ramping up their capacity with
CXone to prepare for increases in demand and numerous healthcare
providers and pharmacies are already relying on CXone to serve
their patients and customers.
“This is a historic moment, and contact centers play a critical
role in efficiently distributing and building trust in the COVID-19
vaccine,” said Paul Jarman, NICE inContact CEO. “As the
vaccine rollout unfolds, information and service centers across the
pharmaceutical industry, health departments, government agencies,
distribution companies and pharmacies need to quickly ramp up
customer service as needed. CXone equips all of them with
innovative cloud technology that drives flexibility, reliability
and agility in the face of such a grand-scale effort.”
Given the high stakes, now more than ever, extreme agility,
scalability and speed to turn-up is crucial for the information and
service centers of all the parties involved in distributing,
administering, and monitoring the vaccine rollout. To provide the
required extreme agility, CXone customer experience cloud provides
rapid deployment on a scalable, secure and reliable platform to
support agencies that are serving on the front line in the fight
against this global pandemic. Contact center agents can efficiently
respond to inbound inquiries about the vaccine as well as
proactively push information to citizens via SMS or digital
messaging. Furthermore, the increased adoption of the CXone digital
self-service and chatbot technologies acts as a force multiplier
scaling and simplifying service in light of the sharp increase in
volumes.
About NICE inContact NICE inContact works with
organizations of all sizes to create extraordinary and trustworthy
customer experiences that create deeper brand loyalty and
relationships that last. With NICE inContact CXoneTM, the
industry’s most complete cloud customer experience platform, we
combine best-in-class Customer Analytics, Omnichannel Routing,
Workforce Optimization, Automation and Artificial Intelligence, all
on an Open Cloud Foundation to help any company transform every
single customer interaction. See how our customer-centric expert
services, innovative software, extensive ecosystem of valuable
partnerships, and over a decade of global experience can help you
transform every experience and customer relationship for lasting
results. NICE inContact is recognized as a market leader by the
leading industry analyst firms. www.niceincontact.com
Trademark Note: NICE and the NICE logo are trademarks or
registered trademarks of NICE Ltd. All other marks are trademarks
of their respective owners. For a full list of NICE’s marks, please
see: www.nice.com/nice-trademarks.
Forward-Looking Statements This press release contains
forward-looking statements as that term is defined in the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements, including the statements by Paul Jarman, are based on
the current beliefs, expectations and assumptions of the management
of NICE Ltd. (the “Company”). In some cases, such forward-looking
statements can be identified by terms such as “believe,” “expect,”
“seek,” “may,” “will,” “intend,” “should,” “project,” “anticipate,”
“plan,” “estimate,” or similar words. Forward-looking statements
are subject to a number of risks and uncertainties that could cause
the actual results or performance of the Company to differ
materially from those described herein, including but not limited
to the impact of changes in economic and business conditions,
including as a result of the COVID-19 pandemic; competition;
successful execution of the Company’s growth strategy; success and
growth of the Company’s cloud Software-as-a-Service business;
changes in technology and market requirements; decline in demand
for the Company's products; inability to timely develop and
introduce new technologies, products and applications; difficulties
or delays in absorbing and integrating acquired operations,
products, technologies and personnel; loss of market share; an
inability to maintain certain marketing and distribution
arrangements; the Company’s dependency on third-party cloud
computing platform providers, hosting facilities and service
partners;, cyber security attacks or other security breaches
against the Company; the effect of newly enacted or modified laws,
regulation or standards on the Company and our products and various
other factors and uncertainties discussed in our filings with the
U.S. Securities and Exchange Commission (the “SEC”). For a more
detailed description of the risk factors and uncertainties
affecting the company, refer to the Company's reports filed from
time to time with the SEC, including the Company’s Annual Report on
Form 20-F. The forward-looking statements contained in this press
release are made as of the date of this press release, and the
Company undertakes no obligation to update or revise them, except
as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210105005660/en/
Corporate Media Contact Cheryl Andrus, +1 801 320 3646,
cheryl.andrus@niceincontact.com
Investors Marty Cohen, +1 551 256 5354, ET,
ir@nice.com Yisca Erez +972 9 775 3798, CET, ir@nice.com
NICE (NASDAQ:NICE)
Historical Stock Chart
From Feb 2024 to Mar 2024
NICE (NASDAQ:NICE)
Historical Stock Chart
From Mar 2023 to Mar 2024